These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 16162003)
1. A new pyridazine series of GABAA alpha5 ligands. van Niel MB; Wilson K; Adkins CH; Atack JR; Castro JL; Clarke DE; Fletcher S; Gerhard U; Mackey MM; Malpas S; Maubach K; Newman R; O'Connor D; Pillai GV; Simpson PB; Thomas SR; MacLeod AM J Med Chem; 2005 Sep; 48(19):6004-11. PubMed ID: 16162003 [TBL] [Abstract][Full Text] [Related]
2. Predictive models for GABAA/benzodiazepine receptor subtypes: studies of quantitative structure-activity relationships for imidazobenzodiazepines at five recombinant GABAA/benzodiazepine receptor subtypes [alphaxbeta3gamma2 (x = 1-3, 5, and 6)] via comparative molecular field analysis. Huang Q; Liu R; Zhang P; He X; McKernan R; Gan T; Bennett DW; Cook JM J Med Chem; 1998 Oct; 41(21):4130-42. PubMed ID: 9767648 [TBL] [Abstract][Full Text] [Related]
4. 5-Substituted imidazole-4-acetic acid analogues: synthesis, modeling, and pharmacological characterization of a series of novel gamma-aminobutyric acid(C) receptor agonists. Madsen C; Jensen AA; Liljefors T; Kristiansen U; Nielsen B; Hansen CP; Larsen M; Ebert B; Bang-Andersen B; Krogsgaard-Larsen P; Frølund B J Med Chem; 2007 Aug; 50(17):4147-61. PubMed ID: 17655213 [TBL] [Abstract][Full Text] [Related]
5. 3,4-Dihydronaphthalen-1(2H)-ones: novel ligands for the benzodiazepine site of alpha5-containing GABAA receptors. Szekeres HJ; Atack JR; Chambers MS; Cook SM; Macaulay AJ; Pillai GV; MacLeod AM Bioorg Med Chem Lett; 2004 Jun; 14(11):2871-5. PubMed ID: 15125950 [TBL] [Abstract][Full Text] [Related]
6. 7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine: a functionally selective gamma-aminobutyric acid(A) (GABA(A)) alpha2/alpha3-subtype selective agonist that exhibits potent anxiolytic activity but is not sedating in animal models. Carling RW; Madin A; Guiblin A; Russell MG; Moore KW; Mitchinson A; Sohal B; Pike A; Cook SM; Ragan IC; McKernan RM; Quirk K; Ferris P; Marshall G; Thompson SA; Wafford KA; Dawson GR; Atack JR; Harrison T; Castro JL; Street LJ J Med Chem; 2005 Nov; 48(23):7089-92. PubMed ID: 16279764 [TBL] [Abstract][Full Text] [Related]
7. TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates. Atack JR; Wafford KA; Tye SJ; Cook SM; Sohal B; Pike A; Sur C; Melillo D; Bristow L; Bromidge F; Ragan I; Kerby J; Street L; Carling R; Castro JL; Whiting P; Dawson GR; McKernan RM J Pharmacol Exp Ther; 2006 Jan; 316(1):410-22. PubMed ID: 16183706 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 3-heterocyclyl-7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines and analogues as subtype-selective inverse agonists for the GABA(A)alpha5 benzodiazepine binding site. Street LJ; Sternfeld F; Jelley RA; Reeve AJ; Carling RW; Moore KW; McKernan RM; Sohal B; Cook S; Pike A; Dawson GR; Bromidge FA; Wafford KA; Seabrook GR; Thompson SA; Marshall G; Pillai GV; Castro JL; Atack JR; MacLeod AM J Med Chem; 2004 Jul; 47(14):3642-57. PubMed ID: 15214791 [TBL] [Abstract][Full Text] [Related]
9. 3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and analogues: high-affinity gamma-aminobutyric acid-A benzodiazepine receptor ligands with alpha 2, alpha 3, and alpha 5-subtype binding selectivity over alpha 1. Carling RW; Moore KW; Street LJ; Wild D; Isted C; Leeson PD; Thomas S; O'Connor D; McKernan RM; Quirk K; Cook SM; Atack JR; Wafford KA; Thompson SA; Dawson GR; Ferris P; Castro JL J Med Chem; 2004 Mar; 47(7):1807-22. PubMed ID: 15027873 [TBL] [Abstract][Full Text] [Related]
10. A pyridazine series of alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety. Lewis RT; Blackaby WP; Blackburn T; Jennings AS; Pike A; Wilson RA; Hallett DJ; Cook SM; Ferris P; Marshall GR; Reynolds DS; Sheppard WF; Smith AJ; Sohal B; Stanley J; Tye SJ; Wafford KA; Atack JR J Med Chem; 2006 Apr; 49(8):2600-10. PubMed ID: 16610803 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, benzodiazepine receptor affinity and anticonvulsant activity of 5-H-indeno[1,2-c]pyridazine derivatives. Altomare C; Campagna F; Carta V; Cellamare S; Carotti A; Genchi G; De Sarro G Farmaco; 1994 May; 49(5):313-23. PubMed ID: 8080613 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, in vitro affinity, and efficacy of a bis 8-ethynyl-4H-imidazo[1,5a]- [1,4]benzodiazepine analogue, the first bivalent alpha5 subtype selective BzR/GABA(A) antagonist. Li X; Cao H; Zhang C; Furtmueller R; Fuchs K; Huck S; Sieghart W; Deschamps J; Cook JM J Med Chem; 2003 Dec; 46(26):5567-70. PubMed ID: 14667209 [TBL] [Abstract][Full Text] [Related]
13. gamma-Aminobutyrate-A receptor modulation by 3-aryl-1-(arylsulfonyl)- 1,4,5,6-tetrahydropyridazines. Rybczynski PJ; Combs DW; Jacobs K; Shank RP; Dubinsky B J Med Chem; 1999 Jul; 42(13):2403-8. PubMed ID: 10395481 [TBL] [Abstract][Full Text] [Related]
14. GABAA receptor pharmacology of fluorinated derivatives of the novel sedative-hypnotic pyrazolopyrimidine indiplon. Wegner F; Deuther-Conrad W; Scheunemann M; Brust P; Fischer S; Hiller A; Diekers M; Strecker K; Wohlfarth K; Allgaier C; Steinbach J; Hoepping A Eur J Pharmacol; 2008 Feb; 580(1-2):1-11. PubMed ID: 18035350 [TBL] [Abstract][Full Text] [Related]
15. Imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepines as potent and highly selective GABAA alpha5 inverse agonists with potential for the treatment of cognitive dysfunction. Buettelmann B; Ballard TM; Gasser R; Fischer H; Hernandez MC; Knoflach F; Knust H; Stadler H; Thomas AW; Trube G Bioorg Med Chem Lett; 2009 Oct; 19(20):5958-61. PubMed ID: 19740657 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, structure-activity relationships at the GABA(A) receptor in rat brain, and differential electrophysiological profile at the recombinant human GABA(A) receptor of a series of substituted 1,2-diphenylimidazoles. Asproni B; Talani G; Busonero F; Pau A; Sanna S; Cerri R; Mascia MP; Sanna E; Biggio G J Med Chem; 2005 Apr; 48(7):2638-45. PubMed ID: 15801854 [TBL] [Abstract][Full Text] [Related]
18. L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptors. Atack JR; Bayley PJ; Seabrook GR; Wafford KA; McKernan RM; Dawson GR Neuropharmacology; 2006 Nov; 51(6):1023-9. PubMed ID: 17046030 [TBL] [Abstract][Full Text] [Related]
19. Discovery of functionally selective 7,8,9,10-tetrahydro-7,10-ethano-1,2,4-triazolo[3,4-a]phthalazines as GABA A receptor agonists at the alpha3 subunit. Russell MG; Carling RW; Atack JR; Bromidge FA; Cook SM; Hunt P; Isted C; Lucas M; McKernan RM; Mitchinson A; Moore KW; Narquizian R; Macaulay AJ; Thomas D; Thompson SA; Wafford KA; Castro JL J Med Chem; 2005 Mar; 48(5):1367-83. PubMed ID: 15743180 [TBL] [Abstract][Full Text] [Related]
20. High affinity central benzodiazepine receptor ligands: synthesis and biological evaluation of a series of phenyltriazolobenzotriazindione derivatives. Primofiore G; Da Settimo F; Taliani S; Salerno S; Novellino E; Greco G; Cosimelli B; Besnard F; Costa B; Montali M; Martini C J Med Chem; 2005 Apr; 48(8):2936-43. PubMed ID: 15828832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]